Skip to main content

Advertisement

SpringerLink
Log in

Migration and invasion in brain neoplasms

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Local invasion of the brain by neoplastic glial cells is a major obstacle to effective treatment of intrinsic brain tumors. Invasion is directly related to histologic malignancy, but occurs to some extent irrespective of tumor grade. Because the brain-to-tumor interface is not well demarcated, total surgical removal is rarely possible; moreover, as invading cells transiently arrest from cell division they are refractory to radiotherapeutic intervention. Invading cells may also be protected from the action of cytotoxic drugs by the presence of an intact blood-brain barrier. The invading cells, having migrated several millimeters or even centimeters from the main focus of the tumor, return to cycle phase under the control of some as yet unknown microenvironmental cue to form a recurrent tumor adjacent to the original site of presentation. Recent cellular and genetic information concerning factors underlying invasion may not only yield suitable targets for adaptation of existing therapies, but may also lead to novel approaches in glioma management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Radhakrishnan K, Bohnen NI, Kurland LT: Epidemiology of brain tumors. In Brain Tumors: A Comprehensive Text. Edited by Morantz RA, Walsh JW. New York: Marcel Dekker; 1994:1–18.

    Google Scholar 

  2. Legler JM, Gloeckler Reis LA, Smith MA, et al.: Brain and other central nervous system cancers: Recent trends in incidence and mortality. J Natl Cancer Inst 1999, 91:1382–1390.

    Article  PubMed  CAS  Google Scholar 

  3. Pilkington GJ: Glioma heterogeneity in vitro: the significance of growth factors and gangliosides. Neuropathol Appl Neurobiol 1992, 18:434–442.

    PubMed  CAS  Google Scholar 

  4. Pilkington GJ: Tumour cell migration in the central nervous system. Brain Pathol 1994, 4:157–166.

    PubMed  CAS  Google Scholar 

  5. Pilkington GJ: The role of the extracellular matrix in neoplastic glial invasion of the nervous system. Brazilian J Med Biol Rese 1996, 29:1159–1172.

    CAS  Google Scholar 

  6. Maidment SL, Rucklidge GJ, Rooprai HK, et al.: An inverse correlation between expression of NCAM-A and the matrixmetalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro. Cancer Lett 1997, 116:71–77.

    Article  PubMed  CAS  Google Scholar 

  7. Gratsa A, Rooprai HK, Rogers JP, et al.: Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia. Anticancer Res 1997, 17:4111–4117.

    PubMed  CAS  Google Scholar 

  8. Merzak A, McCrea S, Koochekpour S, et al.: Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor B1. Br J Cancer 1994, 70:199–203.

    PubMed  CAS  Google Scholar 

  9. Sehgal A, Ricks S, Warrick J, et al.: Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells. Anticancer Res 1999, 19:4947–4953.

    PubMed  CAS  Google Scholar 

  10. Paulus W, Tonn JC: Basement-membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 1994, 80:515–519.

    PubMed  CAS  Google Scholar 

  11. Rooprai HK, Vanmeter T, Panou C, et al.: The role of integrin receptors in aspects of glioma invasion in vitro. Int J Dev Neurosci 1999, 17:613–623.

    Article  PubMed  CAS  Google Scholar 

  12. Merzak A, Koochekpour S, Pilkington GJ: Adhesion of human glioma cell lines to fibronectin, laminin, vitronectin and collagen I is modulated by gangliosides in vitro. Cell Adhes Commun 1995, 3:27–43.

    PubMed  CAS  Google Scholar 

  13. Merzak A, Koochekpour S, McCrea S, et al.: Gangliosides modulate proliferation, migration, and invasiveness of human brain tumor cells in vitro. Mol Chem Neuropathol 1995, 24:121–135.

    PubMed  CAS  Google Scholar 

  14. Koochekpour S, Merzak A, Pilkington GJ: Growth factors and gangliosides stimulate laminin production by human glioma cells in vitro. Neurosci Lett 1995, 186:53–56.

    Article  PubMed  CAS  Google Scholar 

  15. Maidment SL, Merzak A, Koochekpour S, et al.: The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro. Eur J Cancer 1996, 32:868–871.

    Article  Google Scholar 

  16. Koochekpour S, Merzak A, Pilkington GJ: Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett 1996, 102:209–215.

    Article  PubMed  CAS  Google Scholar 

  17. Merzak A, Koochekpour S, Dkhissi F, et al.: Synergism between growth factors in the control of glioma cell proliferation, migration and invasion in vitro. Int J Oncol 1995, 6:1079–1085.

    CAS  Google Scholar 

  18. Rutka JT, Ivanchuk S, Mondal S, et al.: Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. Int J Dev Neurosci 1999, 17:503–515. Important study.

    Article  PubMed  CAS  Google Scholar 

  19. Steck PA, Pershouse MA, Jasser SA, et al.: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 1997, 15:356–362.

    Article  PubMed  CAS  Google Scholar 

  20. Li J, Yen C, Liaw D, et al.: PTEN, a putative protein tyrosine phospatase gene mutated in human brain, breast, and prostatic cancer. Science 1997, 275:1943–1947.

    Article  PubMed  CAS  Google Scholar 

  21. Maier D, Jones G, Li X, Schonthal AH, et al.: The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 1999, 59:5479–5482.

    PubMed  CAS  Google Scholar 

  22. Merzak A, Koochekpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 1994, 54:3988–3992.

    PubMed  CAS  Google Scholar 

  23. Okada H, Yoshida J, Sokabe M, et al.: Suppression of CD44 expression decreased migration and invasion of human glioma cells. Int J Cancer 1996, 66:255–260.

    Article  PubMed  CAS  Google Scholar 

  24. Breyer R, Hussein S, Radu DL, et al.: Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody. J Neurosurg 2000, 92:140–149. Authors conclude that CD44-targeted treatment with specific mAb may represent an effective means for preventing progression of invasive gliblastoma mulitformes.

    Article  PubMed  CAS  Google Scholar 

  25. Okamoto I, Kawano Y, Matsumoto M, et al.: Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J Biol Chem 1999, 274:25525–25534.

    Article  PubMed  CAS  Google Scholar 

  26. Lane RP, Chen XN, Yamakawa K, et al.: Characterization of a highly conserved human homolog to the chicken neural cell surface protein bravo/NrCAM that maps to chromosome band 7q31. Genomics 1996, 35:456–465.

    Article  PubMed  CAS  Google Scholar 

  27. Sehgal A, Boynton AL, Young RF, et al.: Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors. Int J Cancer 1998, 76:451–458.

    Article  PubMed  CAS  Google Scholar 

  28. Sehgal A, Ricks S, Warrick J, et al.: Antisense human neuroglia related cell adhesion molecule hHr-CAM, reduces the tumorigenic properties of human glioblastoma cells. Anticancer Res 1999, 19:4947–4953.

    PubMed  CAS  Google Scholar 

  29. Bouterfa H, Darlapp AR, Klein E, et al.: Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions. J Neurooncol 1999, 44:23–33.

    Article  PubMed  CAS  Google Scholar 

  30. Jung S, Hinek A, Tsugu A, et al.: Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential. Glia 1999, 25:179–189.

    Article  PubMed  CAS  Google Scholar 

  31. Hagel C, Stavrou DK: CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue. Neuropathol Appl Neurobiol 1999, 25:313–318.

    Article  PubMed  CAS  Google Scholar 

  32. Forsyth PA, Wong H, Laing TD, et al.: Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 1999, 79:1828–1835. Data suggest that gelatinase-A and -B and MT1-MMP are important in the pathophysiology of human gliomas.

    Article  PubMed  CAS  Google Scholar 

  33. Nakada M, Nakamura H, Ikeda E, et al.: Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 1999, 154:417–428.

    PubMed  CAS  Google Scholar 

  34. Qin H, Sun Y, Benveniste EN: The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 1999, 274:29130–29137.

    Article  PubMed  CAS  Google Scholar 

  35. Velasco G, Cal S, Merlos-Suarez A, et al.: Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res 2000, 60:877–882.

    PubMed  CAS  Google Scholar 

  36. Rooprai HK, Rucklidge GJ, Panou C, et al.: The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 2000, 82:52–55.

    Article  PubMed  CAS  Google Scholar 

  37. Kitange G, Kishikawa M, Nakayama T, et al.: Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. Mod Pathol 1999, 12:618–626.

    PubMed  CAS  Google Scholar 

  38. Kitange G, Shibata S, Tokunaga Y, et al.: Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Lab Invest 1999, 79:407–416.

    PubMed  CAS  Google Scholar 

  39. Tonn JC, Kerkau S, Hanke A, et al.: Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer 1999, 80:764–772.

    Article  PubMed  CAS  Google Scholar 

  40. Chintala SK, Fueyo J, Gomez-Manzano C, et al.: Adenovirusmediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene 1997, 15:2049–2057.

    Article  PubMed  CAS  Google Scholar 

  41. Demchik LL, Sameni M, Nelson K, et al.: Cathepsin B and glioma invasion. Int J Dev Neurosci 1999, 17:483–494.

    Article  PubMed  CAS  Google Scholar 

  42. Mai J, Finley RL Jr, Waisman DM, et al.: Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J Biol Chem 2000, 275:12806–12812.

    Article  PubMed  CAS  Google Scholar 

  43. Mohan PM, Chintala SK, Mohanam S, et al.: Adenovirusmediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. Cancer Res 1999, 59:3369–3373.

    PubMed  CAS  Google Scholar 

  44. Novak U, Stylli SS, Kaye AH, et al.: Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res 1999, 59:6246–6250.

    PubMed  CAS  Google Scholar 

  45. Lamszus K, Laterra J, Westphal M, et al.: Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci 1999, 17:517–530.

    Article  PubMed  CAS  Google Scholar 

  46. Welch WC, Kornblith PL, Michalopoulos GK, et al.: Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells. Anticancer Res 1999, 19:1635–1640.

    PubMed  CAS  Google Scholar 

  47. Moriyama T, Kataoka H, Koono M, et al.: Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors [review]. Int J Mol Med 1999, 3:531–536.

    PubMed  CAS  Google Scholar 

  48. Mueller MM, Herold-Mende CC, Riede D, et al.: Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 1999, 155:1557–1567.

    PubMed  CAS  Google Scholar 

  49. Miyake K, Kimura S, Nakanishi M, et al.: Transforming growth factor-beta1 stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression. J Neuropathol Exp Neurol 2000, 59:18–28.

    PubMed  CAS  Google Scholar 

  50. Khoshyomn S, Lew S, DeMattia J, et al.: Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. J Neurooncol 1999, 45:111–116.

    Article  PubMed  CAS  Google Scholar 

  51. Chekenya M, Rooprai HK, Davies D, et al.: The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours. Int J Dev Neurosci 1999, 17:421–435.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Neuro-oncology Group, Department of Neuropathology, Institute of Psychiatry, King’s College, London, De Crespigny Park, Denmark Hill, SE5 8AF, London, UK

    Anna J. Bolteus MSc, Michael E. Berens PhD & Geoffrey J. Pilkington PhD, FRCPath

Authors
  1. Anna J. Bolteus MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael E. Berens PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Geoffrey J. Pilkington PhD, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolteus, A.J., Berens, M.E. & Pilkington, G.J. Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 1, 225–232 (2001). https://doi.org/10.1007/s11910-001-0022-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-001-0022-x

Keywords

Search

Navigation